title: [Questions and answers on the role of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease].
authors.affiliation: Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Spain. gisbert@meditex.es
authors.forename: J P
authors.initials: JP
authors.lastname: Gisbert
authors.forename: F
authors.initials: F
authors.lastname: Gomollón
authors.forename: J
authors.initials: J
authors.lastname: Maté
authors.forename: J M
authors.initials: JM
authors.lastname: Pajares
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use; D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016009:Chi-Square Distribution; D002648:Child; D003093:Colitis, Ulcerative / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D016001:Confidence Intervals; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007231:Infant, Newborn; D015212:Inflammatory Bowel Diseases / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D007275:Injections, Intravenous; D007412:Intestinal Fistula / Q000188:drug therapy / Q000209:etiology; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D019804:Mesalamine / Q000008:administration & dosage / Q000627:therapeutic use; D015201:Meta-Analysis as Topic; D016017:Odds Ratio; D010919:Placebos; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D013997:Time Factors
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D010919:Placebos; D019804:Mesalamine; D015122:Mercaptopurine; D001379:Azathioprine
vernacular_title: Preguntas y respuestas sobre el papel de la azatioprina y la 6-mercaptopurina en el tratamiento de la enfermedad inflamatoria intestinal.